ORTEXORTEX News
Tracking SIMO? Get live short interest, options flow, and signals on ORTEX.Sign up free →
SI
Earnings PreviewSIMO

SIMO Options Turn Bullish at Two-Standard-Deviation Extreme Before Q3 Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 29 Oct 2026, 04:09

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

SIMO fell 1.2% over the past week to $219.61, a notable lag against a peer median gain of 3.3%, with AMD up 4.7%, MU up 7.6%, and CEVA up 8.7% across the same period. That underperformance makes the options market's posture all the more striking: the put/call ratio dropped to 0.33, more than two standard deviations below its 20-day average of 0.40, the most call-heavy configuration in recent weeks. Borrow conditions are entirely relaxed. Availability is running at 1,133% of outstanding short interest, meaning roughly eleven shares are available to lend for every one currently borrowed. Cost to borrow is 0.47%, low by any measure. Short interest itself is modest at around 1.65 million shares, up 4.5% on the week but well below October's opening level, and with 2.1 days to cover there is no meaningful squeeze dynamic in play here.

The analyst setup is constructive but shows some cooling. The Street consensus remains positive across coverage, with a mean price target of $363.50 as of late October, roughly 65% above the current price. B. Riley's Craig Ellis trimmed his target from $350 to $288 on October 23, maintaining his Buy rating, a concession that the stock's 20% one-month pullback has outpaced what fundamentals alone would justify. The earlier wave of upgrades, from Susquehanna, Needham, Wedbush, and JPMorgan, all followed the Q1 print in late July, when the stock surged 21% in a single session and added 28% over the following five days. The bull case centres on Gen 5 PCIe controller pricing, which commands premium ASPs versus Gen 4, and a Q2 guidance midpoint of roughly $402 million that implies another sequential revenue step-up driven by enterprise, AI customers, and Chinese market share gains. The bear case is not about direction so much as durability: SSD controller sales fell 5% to 10% sequentially last quarter even as they rose strongly year over year, inventories climbed $93.5 million in the period, and cash fell 32.8% quarter on quarter to $135.7 million.

On the earnings history, the last reported print was among the sharpest one-day moves in the stock's recent record, a 21% gain followed by further strength. The quarter before that also produced a double-digit one-day move. That pattern sets a high implied bar: options traders are not hedging against a repeat disaster, but the stock needs to justify a valuation that has compressed hard over the past month. The PE ratio has fallen roughly 4.2 points over 30 days and the price-to-book ratio is down 1.3 points across the same window, a real-terms de-rating even before the print lands. FMR LLC, the largest disclosed holder at 6.7% of shares, trimmed from 10.0% in its most recent 13G/A filing in August, a reduction worth watching given the direction of travel.

The Q3 print will test whether the $402 million revenue guide is tracking on schedule and whether gross margin is genuinely moving toward the 48.5% to 49.5% range management flagged, because the gap between that aspiration and the recent inventory build is where the two sides of the debate actually disagree.

Stocks in this article

See the live data behind this article on ORTEX.

Open SIMO on ORTEX →

How this article was generated

Generated
29 Oct 2026, 04:37
Data as of
29 Oct 2026, 04:09
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.